Artelo Biosciences, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Daniel S. Farb has reduced his beneficial ownership in Artelo BioSciences, Inc. to 0.8% after selling common stock on October 20 and 21, 2025.
NASDAQ
Artelo Biosciences and Daniel Farb's affiliates enter a standstill agreement, resolving director nominations and setting voting commitments.
NASDAQ
Daniel S. Farb has updated his beneficial ownership in Artelo Biosciences, Inc. to 7.7% following a recent underwritten public offering.
NASDAQ
Activist investor Daniel S. Farb, holding a 9.8% stake in Artelo Biosciences, has nominated himself and Scott D. Pomfret to the company's Board of Directors, citing undervaluation and a desire to unlock shareholder value.